Saghmos Therapeutics
- Biotech or pharma, therapeutic R&D
Saghmos' mission is to develop innovative therapies for life-threatening cardiovascular and renal diseases with unmet medical need. Our product, ST-62516, is poised to enter a Phase 3 study to reduce the risk of Major Adverse Cardiac and Kidney Events.
Address
CTUnited States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}